92 related articles for article (PubMed ID: 19672660)
1. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
[TBL] [Abstract][Full Text] [Related]
2. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
[TBL] [Abstract][Full Text] [Related]
3. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
Downey J; Hamm J; Baliski C
Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
[TBL] [Abstract][Full Text] [Related]
4. Completely resected stage III melanoma controversy - 15 years of national tertiary centre experience.
Peric B; Milicevic S; Perhavec A; Hocevar M; Zgajnar J
Radiol Oncol; 2020 Oct; 55(1):50-56. PubMed ID: 33885234
[TBL] [Abstract][Full Text] [Related]
5. Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.
Egberts F; Hartje C; Schafmayer C; Kaehler KC; von Schönfels W; Hauschild A; Becker T; Egberts JH
Ann R Coll Surg Engl; 2011 Oct; 93(7):514-22. PubMed ID: 22004633
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
Dixon AJ; Kyrgidis A; Steinman HK; Dixon JB; Sladden M; Garbe C; Lallas A; Zachary CB; Leiter-Stöppke U; Smith H; Nirenberg A; Zouboulis CC; Longo C; Argenziano G; Apalla Z; Popescu C; Tzellos T; Anderson S; Nanz L; Cleaver L; Thomas JM
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):741-751. PubMed ID: 38168748
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
Kött J; Zimmermann N; Zell T; Rünger A; Heidrich I; Geidel G; Smit DJ; Hansen I; Abeck F; Schadendorf D; Eggermont A; Puig S; Hauschild A; Gebhardt C
Eur J Cancer; 2024 May; 202():113989. PubMed ID: 38518535
[TBL] [Abstract][Full Text] [Related]
8. Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.
Sutthatarn P; Davidoff AM; Bahrami A; Richard C; Shalini B; Santiago TC; Shulkin BL; Pappo AS; Abdelhafeez A
Pediatr Surg Int; 2024 Mar; 40(1):68. PubMed ID: 38441654
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes.
Kadhum M; Mayr L; Pope-Jones S; Cubitt J; Hemington-Gorse S
J Surg Oncol; 2024 Jun; 129(7):1202-1208. PubMed ID: 38436610
[TBL] [Abstract][Full Text] [Related]
10. The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.
Lee AY; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D; Tariq M; Shapiro R; Beasley G; Contreras CM; Osman I; Lowe M; Zager JS; Berman RS
Ann Surg Oncol; 2020 Dec; 27(13):5259-5266. PubMed ID: 32529271
[TBL] [Abstract][Full Text] [Related]
11. Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.
Winder AA; Boyer Z; Ch'ng S; Stretch JR; Saw RPM; Shannon KF; Pennington TE; Nieweg OE; Varey AHR; Scolyer RA; Thompson JF; Cust AE; Lo SN; Spillane AJ; Smith AL
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38802717
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series.
Bowden A; Zambito J; El-Feghaly J; Andolina JR
Pediatr Hematol Oncol; 2024 May; ():1-10. PubMed ID: 38712383
[TBL] [Abstract][Full Text] [Related]
13. Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type.
Wojcik KY; Hawkins M; Anderson-Mellies A; Hall E; Wysong A; Milam J; Hamilton AS; Cockburn MG
J Am Acad Dermatol; 2023 Apr; 88(4):831-840. PubMed ID: 36610687
[TBL] [Abstract][Full Text] [Related]
14. Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study.
Del Fiore P; Russo I; Ferrazzi B; Monico AD; Cavallin F; Filoni A; Tropea S; Russano F; Di Prata C; Buja A; Collodetto A; Spina R; Carraro S; Cappellesso R; Nicolè L; Chiarion-Sileni V; Pigozzo J; Dall'Olmo L; Rastrelli M; Vecchiato A; Benna C; Menin C; Di Carlo D; Bisogno G; Dei Tos AP; Alaibac M; Mocellin S
Front Oncol; 2021; 11():725523. PubMed ID: 34604064
[TBL] [Abstract][Full Text] [Related]
15. Sentinel Node Biopsy in Young Patients with Atypical Melanocytic Tumors of the Head and Neck.
Pfau D; Tamaki A; Hoppe KR; Honda K; Rezaee R; Zender CA
OTO Open; 2019; 3(2):2473974X19850752. PubMed ID: 31428727
[TBL] [Abstract][Full Text] [Related]
16. Melanoma in children, adolescents and young adults: anatomo-clinical features and prognostic study on 426 cases.
Bagnoni G; Fidanzi C; D'Erme AM; Viacava P; Leoni M; Strambi S; Calani C; Bertocchini A; Morganti R; Spinelli C
Pediatr Surg Int; 2019 Jan; 35(1):159-165. PubMed ID: 30411144
[TBL] [Abstract][Full Text] [Related]
17. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.
Bluemel C; Herrmann K; Giammarile F; Nieweg OE; Dubreuil J; Testori A; Audisio RA; Zoras O; Lassmann M; Chakera AH; Uren R; Chondrogiannis S; Colletti PM; Rubello D
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1750-1766. PubMed ID: 26205952
[TBL] [Abstract][Full Text] [Related]
18. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.
Balch CM; Thompson JF; Gershenwald JE; Soong SJ; Ding S; McMasters KM; Coit DG; Eggermont AM; Gimotty PA; Johnson TM; Kirkwood JM; Leong SP; Ross MI; Byrd DR; Cochran AJ; Mihm MC; Morton DL; Atkins MB; Flaherty KT; Sondak VK
Ann Surg Oncol; 2014 Apr; 21(4):1075-81. PubMed ID: 24531700
[TBL] [Abstract][Full Text] [Related]
19. Age as a prognostic factor in patients with localized melanoma and regional metastases.
Balch CM; Soong SJ; Gershenwald JE; Thompson JF; Coit DG; Atkins MB; Ding S; Cochran AJ; Eggermont AM; Flaherty KT; Gimotty PA; Johnson TM; Kirkwood JM; Leong SP; McMasters KM; Mihm MC; Morton DL; Ross MI; Sondak VK
Ann Surg Oncol; 2013 Nov; 20(12):3961-8. PubMed ID: 23838920
[TBL] [Abstract][Full Text] [Related]
20. Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults.
Reed D; Kudchadkar R; Zager JS; Sondak VK; Messina JL
J Natl Compr Canc Netw; 2013 Jun; 11(6):679-86. PubMed ID: 23744867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
